Marino, A.; Stracquadanio, S.; Bellanca, C.M.; Augello, E.; Ceccarelli, M.; Cantarella, G.; Bernardini, R.; Nunnari, G.; Cacopardo, B.
Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations. Infect. Dis. Rep. 2022, 14, 621-634.
https://doi.org/10.3390/idr14040067
AMA Style
Marino A, Stracquadanio S, Bellanca CM, Augello E, Ceccarelli M, Cantarella G, Bernardini R, Nunnari G, Cacopardo B.
Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations. Infectious Disease Reports. 2022; 14(4):621-634.
https://doi.org/10.3390/idr14040067
Chicago/Turabian Style
Marino, Andrea, Stefano Stracquadanio, Carlo Maria Bellanca, Egle Augello, Manuela Ceccarelli, Giuseppina Cantarella, Renato Bernardini, Giuseppe Nunnari, and Bruno Cacopardo.
2022. "Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations" Infectious Disease Reports 14, no. 4: 621-634.
https://doi.org/10.3390/idr14040067
APA Style
Marino, A., Stracquadanio, S., Bellanca, C. M., Augello, E., Ceccarelli, M., Cantarella, G., Bernardini, R., Nunnari, G., & Cacopardo, B.
(2022). Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations. Infectious Disease Reports, 14(4), 621-634.
https://doi.org/10.3390/idr14040067
